EEC
EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma
| Coordinatore | UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Sito del progetto | http://www.euroewing.eu |
| Totale costo | 7˙556˙053 € |
| EC contributo | 5˙697˙830 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2013-INNOVATION-1 |
| Funding Scheme | CP-FP |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-10-01 - 2018-09-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | coordinator | 718˙848.80 |
| 2 |
THE UNIVERSITY OF BIRMINGHAM
Organization address
address: Edgbaston contact info |
UK (BIRMINGHAM) | participant | 1˙074˙768.00 |
| 3 |
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
Organization address
address: Avenue E. Mounier 83 contact info |
BE (Brussels) | participant | 1˙024˙242.80 |
| 4 |
CENTRE ANTICANCEREUX LEON BERARD
Organization address
address: RUE LAENNEC 28 contact info |
FR (LYON) | participant | 524˙761.00 |
| 5 |
GRUPO ESPANOL DE INVESTIGACION EN SARCOMAS ASOCIACION
Organization address
address: CALLE VELAZQUEZ 7 3RD FLOOR contact info |
ES (MADRID) | participant | 476˙716.40 |
| 6 |
WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Organization address
address: SCHLOSSPLATZ 2 contact info |
DE (MUENSTER) | participant | 407˙387.00 |
| 7 |
UNIVERSITY OF LEEDS
Organization address
address: WOODHOUSE LANE contact info |
UK (LEEDS) | participant | 342˙790.80 |
| 8 |
ISTITUTO ORTOPEDICO RIZZOLI
Organization address
address: VIA DI BARBIANO 1/10 contact info |
IT (BOLOGNA) | participant | 294˙717.50 |
| 9 |
INSTITUT CURIE
Organization address
address: 26, rue d'Ulm contact info |
FR (PARIS) | participant | 195˙750.00 |
| 10 |
THE UNIVERSITY OF MANCHESTER
Organization address
address: OXFORD ROAD contact info |
UK (MANCHESTER) | participant | 118˙999.20 |
| 11 |
Servicio Andaluz de Salud
Organization address
address: AVENIDA DE LA CONSTITUCION 18 contact info |
ES (SEVILLA) | participant | 106˙200.00 |
| 12 |
ACADEMISCH ZIEKENHUIS LEIDEN
Organization address
address: Albinusdreef 2 contact info |
NL (LEIDEN) | participant | 79˙183.20 |
| 13 |
SKANE LANS LANDSTING
Organization address
city: KRISTIANSTAD contact info |
SE (KRISTIANSTAD) | participant | 73˙008.00 |
| 14 |
INSTITUT GUSTAVE ROUSSY
Organization address
address: Rue Camille Desmoulins 39 contact info |
FR (VILLEJUIF) | participant | 72˙430.80 |
| 15 |
UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST
Organization address
address: EUSTON ROAD 250 contact info |
UK (LONDON) | participant | 69˙024.60 |
| 16 |
ST. ANNA KINDERKREBSFORSCHUNG
Organization address
address: ZIMMERMANNPLATZ 10 contact info |
AT (WIEN) | participant | 58˙200.00 |
| 17 |
SARCOMA PATIENTS EURONET EV
Organization address
address: USA Strasse 1 contact info |
DE (Bad Nauheim) | participant | 19˙440.00 |
| 18 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | participant | 18˙000.00 |
| 19 |
UNIVERSITATSKLINIKUM ERLANGEN
Organization address
address: Maximiliansplatz 2 contact info |
DE (ERLANGEN) | participant | 13˙660.80 |
| 20 |
INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER ASSOCIATION
Organization address
address: RUE EDOUARD VAILLANT 114 contact info |
FR (VILLEJUIF) | participant | 9˙702.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Ewing Sarcomas (ES) are fatal, rare bone cancers particularly affecting young people. About 60% of patients achieve long term survival with current treatment but there has been no improvement in this proportion for 25 years. Treatment is unsuccessful because chemotherapy fails to prevent the development of, or to effectively treat established, metastases. In addition, of the 600 new cases of ES occurring in the EU each year, less than half will receive treatment ‘appropriate’ to deliver the most favourable outcome. The EUROEWING Consortium (EEC) is a coalition of clinical study groups bringing together the most active clinicians and scientists in Europe dedicated to improving survival from ES. This initiative can achieve this through an integrated programme of investigator-driven, inclusive clinical trials that are rigorously designed, conducted, analysed and reported, and underpinned by complementary embedded translational research. These include i) a first line randomised study in patients of all ages with ES which defines standards of care to prevent development of metastases and serves as a backbone for implementation of new agents, and ii) a randomised study of current second line chemotherapy in patients of all ages with ES which will serve as a platform for testing of new agents. Companion studies in association with these trials will be performed investigating tumour biology, underlying causes of differential response and toxicity, and other biomarkers. The programme will be supported by new initiatives for the involvement of patients in research planning and operation. Through collaborative working, the EEC will provide ES patients with greater access to clinical trials, allow efficient acquisition of knowledge and deliver clinically meaningful results within the lifetime of the grant, thereby contributing to improved survival from ES.'